Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx)
Agency: Advanced Research Projects Agency for Health
- 93.384 -- ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H)
Archived opportunityLast Updated: May 13, 2026
Important dates
- Archived: February 18, 2024
- Closed: February 16, 2024
Award details
- Expected project funding: Not specified
- Expected awards: Not specified
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:75N99224R00001
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Science technology and other research and development
- Category Explanation:Not specified
History
- Posted date: November 21, 2023
- Archive date: February 18, 2024
- Version: 2
Summary
The Advanced Research Projects Agency for Health (ARPA-H) posts this funding opportunity in support of its Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx) Program. ARPA-H anticipates multiple awards and award types will result from this announcement.
Interested parties are invited to review attached APECx Research & Development Solicitation No. 75N99224R00001. Abstracts are due December 15, 2023, 9:00 AM ET. Proposals will be invite-only and will be due February 16, 2024, 5:00 PM ET. An abstract must be submitted to be invited to submit a proposal.
Please ensure to follow this opportunity for any updates.
For more information about APECx, please visit https://arpa-h.gov/engage/programs/apecx/.
Please note that the APEX Accelerators government contracting resource for small businesses notice is included on all SAM.gov postings and is unrelated to the ARPA-H APECx program.
Eligibility
Miscellaneous
- Unrestricted
Additional information on eligibility
Documents
No documents are currently available.
